Why GRAIL, Inc.’s (GRAL) Stock Is Up 7.47%
As of Tuesday, November 03, GRAIL, Inc.’s GRAL share price has surged by 7.47%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Commentary & Analysis
Why GRAIL, Inc.’s (GRAL) Stock Is Down 5.63%
As of Monday, November 02, GRAIL, Inc.’s GRAL share price has dipped by 5.63%, which has investors questioning if this is right time to buy.Tudor Pop
Why GRAIL, Inc.’s (GRAL) Stock Is Down 9.39%
As of Friday, October 30, GRAIL, Inc.’s GRAL share price has dipped by 9.39%, which has investors questioning if this is right time to buy.Michael Rose
Why GRAIL, Inc.’s (GRAL) Stock Is Up 5.03%
As of Wednesday, October 28, GRAIL, Inc.’s GRAL share price has surged by 5.03%, which has investors questioning if this is right time to sell.Jenna Brashear
Why GRAIL, Inc.’s (GRAL) Stock Is Up 7.29%
As of Tuesday, October 27, GRAIL, Inc.’s GRAL share price has surged by 7.29%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | GRAL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,241.2 | $219.1 | 71% |
|
| Shares Out (Mil) | 43.1 | 53.4 | 44% |
|
| Institutional Ownership | 97.4% | 92.9% | 73% |
|
| Float (Mil) | 34.3 | 41.4 | 38% |
|
| Beta | 3.25 | 0.95 | 98% |
|
| Avg Daily Volume (000s) | 990 | 455 | 69% |
|
| Price Change (52-week) |
53.3% | 46.6% | 87% |
|
| Growth | GRAL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (5.5%) | (10.1%) | 33% |
|
| EPS (5yr) | (34.5%) | 15.8% | 7 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 33.5% | (15.7%) | 88% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 5 | 4 | |
| Current EPS | ($1.899) | ($7.515) | ($8.250) | |
| Month Ago EPS | ($1.899) | ($7.510) | ($8.238) | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($2.380) | ($9.143) | ($9.717) | |
| Year/Year Chg | (25.7%) | (32.4%) | (33.7%) | |
| Financials | GRAL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $165 | $37 | 30% |
|
| Net Income (TTM) (Mil) | ($392) | ($44) | 4% |
|
| EPS (TTM) | ($9.749) | ($1.600) | 5% |
|
| Operating Cash Flow (TTM) (Mil) | ($295) | ($33) | 3% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $81 | $4 | 43% |
|
| Enterprise Value (Q1) (Mil) | $2,533 | $174 | 52% |
|
| Valuation | GRAL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.45 | 2.11 | 61% |
|
| P/E | na | 20.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | GRAL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 49.7% | 66.0% | 62% |
|
| Net Margin | (236.9%) | (70.6%) | 4% |
|
| ROA | (14.1%) | (47.0%) | 23% |
|
| ROE | (16.1%) | (52.2%) | 25% |
|
| Liabilities to Assets | 10.6% | 29.6% | 6% |
|
| F-Score | 5 | 2 | 50% |
|
GRAIL, Inc. did not pass any screens on 11/3/2026.
